Kejiang Lin

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 13

Top Venues

Journal of chemical information and modeling

Future medicinal chemistry

Journal of cheminformatics

Expert opinion on therapeutic targets

China Pharmaceutical University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

China Pharmaceutical University Jul 01 2000

China

Professor of Medicinal Chemistry :: Dept. of Medicinal Chemistry

Publications

Zhihao Gu, Yong Yan, Hanwen Liu, Di Wu, Hequan Yao, Kejiang Lin, Xuanyi Li
Discovery of Covalent Lead Compounds Targeting 3CL Protease with a Lateral Interactions Spiking Neural Network. Journal of chemical information and modeling 64 (8) (2024)
Yong Yan, Hanwen Liu, Di Wu, Zhihao Gu, Wenhao Guo, Hequan Yao, Kejiang Lin, Xuanyi Li
Design, synthesis and biological evaluation of novel 3C-like protease inhibitors as lead compounds against SARS-CoV-2. Future medicinal chemistry 16 (9) (2024)
Zhihao Gu, Yong Yan, Hanwen Liu, Di Wu, Hequan Yao, Kejiang Lin, Xuanyi Li
Discovery of Covalent Lead Compounds Targeting 3CL Protease with a Lateral Interactions Spiking Neural Network. Journal of chemical information and modeling 64 (8) (2024)
Zhihao Gu, Yong Yan, Hanwen Liu, Di Wu, Hequan Yao, Kejiang Lin, Xuanyi Li
Discovery of Covalent Lead Compounds Targeting 3CL Protease with a Lateral Interactions Spiking Neural Network. Journal of chemical information and modeling 64 (8) (2024)
Yong Yan, Hanwen Liu, Di Wu, Zhihao Gu, Wenhao Guo, Hequan Yao, Kejiang Lin, Xuanyi Li
Design, synthesis and biological evaluation of novel 3C-like protease inhibitors as lead compounds against SARS-CoV-2. Future medicinal chemistry 16 (9) (2024)
Yong Yan, Hanwen Liu, Di Wu, Zhihao Gu, Wenhao Guo, Hequan Yao, Kejiang Lin, Xuanyi Li
Design, synthesis and biological evaluation of novel 3C-like protease inhibitors as lead compounds against SARS-CoV-2. Future medicinal chemistry (2024)
Zhihao Gu, Yong Yan, Hanwen Liu, Di Wu, Hequan Yao, Kejiang Lin, Xuanyi Li
Discovery of Covalent Lead Compounds Targeting 3CL Protease with a Lateral Interactions Spiking Neural Network. Journal of chemical information and modeling 64 (8) (2024)
Zhihao Gu, Yong Yan, Hanwen Liu, Di Wu, Hequan Yao, Kejiang Lin, Xuanyi Li
Discovery of Covalent Lead Compounds Targeting 3CL Protease with a Lateral Interactions Spiking Neural Network. Journal of chemical information and modeling (2024)
Yong Yan, Hanwen Liu, Di Wu, Zhihao Gu, Wenhao Guo, Hequan Yao, Kejiang Lin, Xuanyi Li
Design, synthesis and biological evaluation of novel 3C-like protease inhibitors as lead compounds against SARS-CoV-2. Future medicinal chemistry 16 (9) (2024)
Yong Yan, Hanwen Liu, Di Wu, Zhihao Gu, Wenhao Guo, Hequan Yao, Kejiang Lin, Xuanyi Li
Design, synthesis and biological evaluation of novel 3C-like protease inhibitors as lead compounds against SARS-CoV-2. Future medicinal chemistry 16 (9) (2024)
Zhihao Gu, Yong Yan, Hanwen Liu, Di Wu, Hequan Yao, Kejiang Lin, Xuanyi Li
Discovery of Covalent Lead Compounds Targeting 3CL Protease with a Lateral Interactions Spiking Neural Network. Journal of chemical information and modeling 64 (8) (2024)
Xuanyi Li, Yinqiu Xu, Hequan Yao, Kejiang Lin
Chemical space exploration based on recurrent neural networks: applications in discovering kinase inhibitors. Journal of cheminformatics 12 (1) (2020)
Lingman Ma, Xuanyi Li, Zhaoshi Bai, Xinhao Lin, Kejiang Lin
AdipoRs- a potential therapeutic target for fibrotic disorders. Expert opinion on therapeutic targets 23 (2) (2018)

Kejiang Lin.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Kejiang Lin